C erebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a monogenic cerebral small vessel disease caused by mutations of the NOTCH3 gene. 1 Recently, in a mouse model of CADASIL, intramyelinic edema was detected in the white matter (WM), which may represent the initial lesions of the disease. 2 If this holds true in human patients, one would expect to find a larger volume of WM at the early stage of the disease. In the subgroup with the highest volume of WM hyperintensities (WMH) from a large cohort of 278 patients with CADASIL, a positive association between WMH volume and normalized brain volume was observed. 3 In the absence of a control group, it was however not possible to confirm that brain volume was actually increased. In addition, WM volume was not specifically measured. Unexpected biases were also still possible in unselected patients. For instance, more severe patients are known to develop brain atrophy with increasing number of lacunar infarcts. 4 Thus, patients with high loads of lacunar lesions may have lower brain and lower WM volumes with reduced capacity to develop extensive WMH. Finally, patients with larger signal abnormalities on MRI may also have higher probability of postprocessing errors of segmentation.
Demonstration of a larger volume of WM in patients in comparison with controls may be difficult because coexisting subcortical lesions may render the estimation of WM volume imprecise. Moreover, measures of WM volume rely on gray to WM contrast, which is altered in CADASIL. 5 A demonstration of a larger WM volume would be strengthened by results obtained through indirect but more reliable measures. We hypothesize that, if WM volume is larger, the ratio of the cortical surface area (CSA) to the volume Background and Purpose-Recently, in a mouse model of cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy, a monogenic cerebral small vessel disease, intramyelinic edema was detected in the white matter (WM) early during the course of the disease. We hypothesized that if this mechanism holds true in patients, it would translate in larger WM volume. We aimed to measure WM volume in patients with cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy in comparison with age-and sex-matched controls, along with the ratio of cortical surface area to the volume of brain hemispheres as an indirect measure that should be reduced in patients. In the present study, we aimed to evaluate whether the volume of WM is larger in patients with CADASIL using both direct and indirect measures at the early clinical stage of the disease.
Methods-Twenty

Methods Participants
Patients with CADASIL at the early clinical stage of the disease (Mini Mental State Examination score >24 and modified Rankin scale ≤1) were recruited from our French national database on a voluntary basis. Controls were drawn from a local database of healthy volunteers free of any known history of neurological disorder and without symptoms of cognitive impairment or disability as evaluated by a structured interview. Subjects included for this study had highquality 3DT1 images allowing the study of cortex structure (20 patients and 27 healthy controls). A local ethics committee validated the protocol and all subjects gave their written consent for participating in the study.
Data Acquisition
Three-dimensional T 1 -weighted images used for volumetric analyses were obtained at 3 Tesla with a Tim-Trio MRI scanner (Siemens Healthcare, Erlangen, Germany) equipped with a 12-channel head coil, using a standard sagittal magnetization-prepared rapid acquisition gradient echo (MPRAGE) sequence (in plane resolution: 1×1 mm 2 ; slice thickness, 1.1 mm; repetition time, 2300 ms; echo time, 2.98 ms; inversion time, 900 ms; flip angle, 9°; bandwidth, 238 Hz/pixel; and time of acquisition, 7′45 minutes). Lesion masks, volumes of lacunes and of WMH, and number of microhemorrhages were determined from 3DT1, fluid-attenuated inversion-recovery and T 2 * gradient echo images obtained within 6 months on a 1.5T Signa scanner (GE Healthcare, Milwaukee, WI).
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Data Processing and Statistical Analysis
Three-dimensional T 1 -weighted images were processed using FreeSurfer. 8 Volumes of WMH (WMH V ) were calculated by multiplying the number of voxels corresponding to WMH masks by the voxel size. 7 Masks of WMH were registered to 3DT1 images and, as previously reported, 7 voxel intensity inside WMH was set up to an average intensity close to that of normal-appearing WM to overcome segmentation difficulties possibly induced by WMH in patients. Reconstructed data sets were systematically inspected for accuracy. Temporal poles as defined in the Desikan-Killiany atlas were excluded from the CSA and cortical thickness measurements because of the frequent signal abnormalities in these regions that may affect the accurate detection of the gray-WM boundary. The volume of brain hemispheres (BH V ), volume of hemispheric WM including hyperintensities (WM V ), average cortical thickness, and CSA were computed for each subject. Ratio of CSA to the BH V was defined as R SV =CSA/ BH V 2/3 to respect dimensionality. Statistical analyses were made using the R software (http://www.rproject.org/). Between-group comparisons were performed using χ 2 or t tests depending on variable type and distribution. Linear regression modeling was used to test whether volumetric or surface measures differ between groups, with adjustment for potential confounder (age, sex, BH V , and intracranial cavity volume) when necessary. ║In patients with such lesions (number given in parentheses).
Results
Characteristics of the 2 groups and results from image processing are detailed in the
Figure.
Increase of white matter volume in patients with cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and its consequences on the ratio of cortical surface area to the volume of brain hemispheres. A, Comparison of native 3DT1 scans illustrating our results for 3 patients and controls of increasing age. Volume of brain hemispheres seems larger in patients with smaller ventricles. Ratio of cortical surface area to the volume of brain hemisphere is smaller in patients than in controls. For general understanding, arrows point out some abnormal white matter areas. B, Putative mechanisms to explain the observed differences between controls and patients, described on a schematic of axial MRI slices: (1) classical small vessel disease-related mechanism leading to global brain atrophy; (2) white matter edema leading to an increase of white matter volume; and (3) combination of (1) and (2) 
Discussion
In the present study, we observed that patients with CADASIL have larger WM V compared with age-and sex-matched controls at the early stage of clinical manifestations of the disease. We also observed a trend for association between larger WM V and larger WMH V among patients (Figure [A] ). The larger WM V were associated with smaller ratios of CSA to BH V in patients. Thus, both direct and indirect measures are consistent with the hypothesis of larger WM V in patients compared with age-and sex-matched controls. In addition to the present findings, we observed that CSA is smaller in patients after adjustment for brain volume, in the absence of significant difference of cortical thickness. These results may be explained by the combination of 2 distinct but concurrent mechanisms: one leading to global brain atrophy with reduction of WM V , cortical volume, and cortical surface, as usually thought in ischemic small vessel disease ( Figure  [B] , mechanism 1); a second mechanism leading to a selective increase of WM V , which would compensate the global brain tissue loss, resulting in a lower ratio of CSA to BH V without apparent brain atrophy (Figure [B] , mechanism 2). The second phenomenon would be explained by intramyelinic edema within the WM. The concomitant occurrence of both mechanisms would thus provide an explanation of the observed difference between patients and controls (Figure [B] , mechanism 3). These competing mechanisms may explain why brain atrophy is the most visible feature observed in severe CADASIL patients, particularly in samples including individuals with high loads of lacunar lesions, 4,9 whereas patients with the most extensive WMH seem to have larger brains than controls. 3, 10 This would also explain some recent unexpected results from the literature. Indeed, in a 7-year follow-up study of patients with CADASIL aged 51.4 years, significant ventricular enlargement was detected in controls but not in patients. 11 Alternatively, we cannot exclude that ratio of CSA to BH V is lower in patients because of innate group differences possibly related to NOTCH3 mutations. However, this would not explain the larger brain volumes previously observed in patients with the highest extent of WMH. 3 Our study has some limitations. First, the sample size was small. In addition, the methodology used to measure WM V may not be completely reliable as WM is frankly abnormal in patients with CADASIL (see Figure) . Half of the patients had lacunes in the WM, which may also alter the WM V estimation. Finally, WM is darker on 3DT1 sequences in patients with CADASIL compared with controls, 5 leading to potential errors when estimating the relative volume of gray and WM. However, all these potential sources of error would lead to underestimation of WM V in patients and are thus unlikely to explain the present results. Moreover, the measures obtained using a proxy of WM V , more reliable, showed results consistent with our initial hypothesis. Given the recruitment criteria of the present study, we could not evaluate whether similar findings can be observed in later stages of CADASIL. However, severe forms of the disease are associated with important brain atrophy 12 and severe signal and contrast alterations 5 that would render this study difficult. Finally, additional investigations are needed to evaluate whether these early alterations are associated with cognitive dysfunction.
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